ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms.

Lindsay M Gurska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.